世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
創傷被覆材の市場規模、シェア、動向分析レポート：製品別（従来型ドレッシング材、高機能ドレッシング材）、用途別（慢性創傷、急性創傷）、最終用途別、地域別、セグメント別予測、2024年～2030年Wound Dressing Market Size, Share & Trends Analysis Report By Product (Traditional Dressing, Advanced Dressing), By Application (Chronic Wounds, Acute Wounds), By End-use, By Region, And Segment Forecasts, 2024 - 2030 創傷被覆材市場の成長と動向 Grand View Research社の最新レポートによると、世界の創傷被覆材市場規模は2030年までに189億米ドルに達すると推定されている。同市場は2024年から2030年にかけて年平均成長率4.1... もっと見る
1～３営業日 
サマリー創傷被覆材市場の成長と動向Grand View Research社の最新レポートによると、世界の創傷被覆材市場規模は2030年までに189億米ドルに達すると推定されている。同市場は2024年から2030年にかけて年平均成長率4.16％で成長すると予測されている。慢性創傷に悩む人々の増加、技術的に進歩したドレッシングの増加、外傷性事故の事例の増加が市場の主要な推進要因になると予測されている。 糖尿病のような慢性疾患の増加により、糖尿病性足潰瘍に苦しむ人の数は増加している。例えば、国際糖尿病連合（IDF）によると、ヨーロッパに住む20～79歳の推定人口6,100万人が糖尿病を患っている。同様に、米国生物工学情報センター（NCBI）によると、糖尿病性足潰瘍の世界的な発生率は、年間910万人から2610万人である。このように、糖尿病および糖尿病性足潰瘍患者の増加は、創傷包帯製品に対する需要を増加させている。 さらに、火傷、銃撃、交通事故などの外傷性事故が世界的に増加している。例えば、2023年10月の世界保健機関（WHO）の統計によると、全世界で約1,100万件の火傷が発生し、全世界で18万人が死亡している。同様に、NCBIによれば、毎日、世界で3万件以上の熱傷症例が登録されている。したがって、世界的な熱傷症例の増加は、予測期間にわたって市場を促進すると予想される。 創傷被覆材市場レポートハイライト - 製品別では、アドバンスドドレッシング分野が2023年の市場を支配した。これは、世界的に外傷性事故が増加していることに起因している。 - 用途別では、慢性創傷分野が2023年の市場を独占 - 最終用途別では、病院セグメントが2023年の市場を支配した。この背景には、外科手術の増加や病院数の増加がある。 - 2023年の市場は北米が支配的であった。この優位性は、整備された医療インフラ、認知度の向上、同地域における主要プレイヤーの存在に起因する。 目次Table of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Product 1.1.2. Application 1.1.3. End-use 1.1.4. Regional scope 1.1.5. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.3.5.1. Data for primary interviews in North America 1.3.5.2. Data for primary interviews in Europe 1.3.5.3. Data for primary interviews in Asia Pacific 1.3.5.4. Data for primary interviews in Latin America 1.3.5.5. Data for Primary interviews in MEA 1.4. Information or Data Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis (Model 1) 1.6.2. Approach 1: Commodity flow approach 1.6.3. Volume price analysis (Model 2) 1.6.4. Approach 2: Volume price analysis 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Product outlook 2.2.2. Application outlook 2.2.3. End-use outlook 2.2.4. Regional outlook 2.3. Competitive Insights Chapter 3. Wound Dressing Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Market Dynamics 3.2.1. Market driver analysis 3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities 3.2.1.2. Introduction of innovative and advanced wound products 3.2.1.3. Rising geriatric population 3.2.1.4. Increasing number of ambulatory surgical centers (ASCs) 3.2.1.5. Increasing number of accidents 3.2.1.6. Steep rise in the number of hospitals & urgent care centers and increase in hospital admissions 3.2.1.7. Improvements in public and private hospital infrastructure 3.2.2. Market restraint analysis 3.2.2.1. Delayed diagnosis and lower treatment rates in emerging nations 3.2.2.2. High cost of advanced wound care products and chronic wound treatments 3.2.2.3. Stringent manufacturing policies 3.3. Wound dressing market analysis tools 3.3.1. Industry Analysis - Porter’s 3.3.1.1. Supplier power 3.3.1.2. Buyer power 3.3.1.3. Substitution threat 3.3.1.4. Threat of new entrant 3.3.1.5. Competitive rivalry 3.3.2. PESTEL Analysis 3.3.2.1. Political landscape 3.3.2.2. Technological landscape 3.3.2.3. Economic landscape Chapter 4. Wound Dressing Market: Product Estimates & Trend Analysis 4.1. Definitions and Scope 4.1.1. Advanced dressings 4.1.2. Traditional dressings 4.2. Product Market Share, 2023 & 2030 4.3. Segment Dashboard 4.4. Global Wound Dressing Market by Product Outlook 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 4.5.1. Traditional wound dressing 4.5.1.1. Traditional wound dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.2. Gauze 4.5.1.2.1. Gauze market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.3. Tape 4.5.1.3.1. Tape market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.4. Bandages 4.5.1.4.1. Bandages market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.5. Cotton 4.5.1.5.1. Cotton market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.6. Others 4.5.1.6.1. Others market estimates and forecast 2018 to 2030 (USD Million) 4.5.2. Advanced dressings 4.5.2.1. Advanced dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2. Moist dressings 4.5.2.2.1. Moist dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2.2. Foam dressing 4.5.2.2.2.1. Foam dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2.3. Hydrocolloid dressing 4.5.2.2.3.1. Hydrocolloid dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2.4. Film dressing 4.5.2.2.4.1. Film dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2.5. Alginate dressing 4.5.2.2.5.1. Alginate dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2.6. Hydrogel dressing 4.5.2.2.6.1. Hydrogel dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2.7. Collagen dressing 4.5.2.2.7.1. Collagen dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2.8. Other advanced dressing 4.5.2.2.8.1. Other advanced dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.3. Antimicrobial dressings 4.5.2.3.1. Antimicrobial dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.3.2. Silver 4.5.2.3.2.1. Silver market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.3.3. Non-silver 4.5.2.3.3.1. Non-silver market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.4. Active dressings 4.5.2.4.1. Active dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.4.2. Biomaterials 4.5.2.4.2.1. Biomaterials market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.4.3. Skin-substitutes 4.5.2.4.3.1. Skin-substitutes market estimates and forecast 2018 to 2030 (USD Million) Chapter 5. Wound dressing Market: Application Estimates & Trend Analysis 5.1. Definitions and Scope 5.1.1. Chronic wounds 5.1.2. Acute wounds 5.2. Application Market Share, 2023 & 2030 5.3. Segment Dashboard 5.4. Global Wound Dressing Market by Application Outlook 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 5.5.1. Chronic wounds 5.5.1.1. Market estimates and forecast 2018 to 2030 (USD million) 5.5.1.2. Diabetic foot ulcers 5.5.1.2.1. Market estimates and forecast 2018 to 2030 (USD Million) 5.5.1.3. Pressure ulcers 5.5.1.3.1. Market estimates and forecast 2018 to 2030 (USD Million) 5.5.1.4. Venous leg ulcers 5.5.1.4.1. Market estimates and forecast 2018 to 2030 (USD Million) 5.5.1.5. Other chronic wounds 5.5.1.5.1. Market estimates and forecast 2018 to 2030 (USD Million) 5.5.2. Acute wounds 5.5.2.1. Market estimates and forecast 2018 to 2030 (USD million) 5.5.2.2. Surgical & traumatic wounds 5.5.2.2.1. Market estimates and forecast 2018 to 2030 (USD Million) 5.5.2.3. Burns 5.5.2.3.1. Market estimates and forecast 2018 to 2030 (USD Million) Chapter 6. Wound dressing Market: End-use Estimates & Trend Analysis 6.1. Definitions and Scope 6.1.1. Hospitals 6.1.2. Outpatient facilities 6.1.3. Home healthcare 6.1.4. Research & manufacturing 6.2. End-use Market Share, 2023 & 2030 6.3. Segment Dashboard 6.4. Global Wound Dressing Market by End-use Outlook 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 6.5.1. Hospitals 6.5.1.1. Market estimates and forecast 2018 to 2030 (USD million) 6.5.2. Outpatient facilities 6.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million) 6.5.3. Home healthcare 6.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million) 6.5.4. Research & manufacturing 6.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million) Chapter 7. Wound dressing Market: Regional Estimates & Trend Analysis 7.1. Regional Market Share Analysis, 2023 & 2030 7.2. Regional Market Dashboard 7.3. Global Regional Market Snapshot 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030: 7.5. North America 7.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 7.5.2. U.S. 7.5.2.1. Key country dynamics 7.5.2.2. Competitive scenario 7.5.2.3. Regulatory framework 7.5.2.4. Reimbursement scenario 7.5.2.5. U.S. market estimates and forecasts, 2018 - 2030 7.5.3. Canada 7.5.3.1. Key country dynamics 7.5.3.2. Competitive scenario 7.5.3.3. Regulatory framework 7.5.3.4. Reimbursement scenario 7.5.3.5. Canada market estimates and forecasts, 2018 - 2030 7.6. Europe 7.6.1. UK 7.6.1.1. Key country dynamics 7.6.1.2. Competitive scenario 7.6.1.3. Regulatory framework 7.6.1.4. Reimbursement scenario 7.6.1.5. UK market estimates and forecasts, 2018 - 2030 7.6.2. Germany 7.6.2.1. Key country dynamics 7.6.2.2. Competitive scenario 7.6.2.3. Regulatory framework 7.6.2.4. Reimbursement scenario 7.6.2.5. Germany market estimates and forecasts, 2018 - 2030 7.6.3. France 7.6.3.1. Key country dynamics 7.6.3.2. Competitive scenario 7.6.3.3. Regulatory framework 7.6.3.4. Reimbursement scenario 7.6.3.5. France market estimates and forecasts, 2018 - 2030 7.6.4. Italy 7.6.4.1. Key country dynamics 7.6.4.2. Competitive scenario 7.6.4.3. Regulatory framework 7.6.4.4. Reimbursement scenario 7.6.4.5. Italy market estimates and forecasts, 2018 - 2030 7.6.5. Spain 7.6.5.1. Key country dynamics 7.6.5.2. Competitive scenario 7.6.5.3. Regulatory framework 7.6.5.4. Reimbursement scenario 7.6.5.5. Spain market estimates and forecasts, 2018 - 2030 7.6.6. Denmark 7.6.6.1. Key country dynamics 7.6.6.2. Competitive scenario 7.6.6.3. Regulatory framework 7.6.6.4. Reimbursement scenario 7.6.6.5. Denmark market estimates and forecasts, 2018 - 2030 7.6.7. Sweden 7.6.7.1. Key country dynamics 7.6.7.2. Competitive scenario 7.6.7.3. Regulatory framework 7.6.7.4. Reimbursement scenario 7.6.7.5. Sweden market estimates and forecasts, 2018 - 2030 7.6.8. Norway 7.6.8.1. Key country dynamics 7.6.8.2. Competitive scenario 7.6.8.3. Regulatory framework 7.6.8.4. Reimbursement scenario 7.6.8.5. Norway market estimates and forecasts, 2018 - 2030 7.7. Asia Pacific 7.7.1. Japan 7.7.1.1. Key country dynamics 7.7.1.2. Competitive scenario 7.7.1.3. Regulatory framework 7.7.1.4. Reimbursement scenario 7.7.1.5. Japan market estimates and forecasts, 2018 - 2030 7.7.2. India 7.7.2.1. Key country dynamics 7.7.2.2. Competitive scenario 7.7.2.3. Regulatory framework 7.7.2.4. Reimbursement scenario 7.7.2.5. India market estimates and forecasts, 2018 - 2030 7.7.3. China 7.7.3.1. Key country dynamics 7.7.3.2. Competitive scenario 7.7.3.3. Regulatory framework 7.7.3.4. Reimbursement scenario 7.7.3.5. China market estimates and forecasts, 2018 - 2030 7.7.4. South Korea 7.7.4.1. Key country dynamics 7.7.4.2. Competitive scenario 7.7.4.3. Regulatory framework 7.7.4.4. Reimbursement scenario 7.7.4.5. South Korea market estimates and forecasts, 2018 - 2030 7.7.5. Australia 7.7.5.1. Key country dynamics 7.7.5.2. Competitive scenario 7.7.5.3. Regulatory framework 7.7.5.4. Reimbursement scenario 7.7.5.5. Australia market estimates and forecasts, 2018 - 2030 7.7.6. Thailand 7.7.6.1. Key country dynamics 7.7.6.2. Competitive scenario 7.7.6.3. Regulatory framework 7.7.6.4. Reimbursement scenario 7.7.6.5. Thailand market estimates and forecasts, 2018 - 2030 7.8. Latin America 7.8.1. Brazil 7.8.1.1. Key country dynamics 7.8.1.2. Competitive scenario 7.8.1.3. Regulatory framework 7.8.1.4. Reimbursement scenario 7.8.1.5. Brazil market estimates and forecasts, 2018 - 2030 7.8.2. Mexico 7.8.2.1. Key country dynamics 7.8.2.2. Competitive scenario 7.8.2.3. Regulatory framework 7.8.2.4. Reimbursement scenario 7.8.2.5. Mexico market estimates and forecasts, 2018 - 2030 7.8.3. Argentina 7.8.3.1. Key country dynamics 7.8.3.2. Competitive scenario 7.8.3.3. Regulatory framework 7.8.3.4. Reimbursement scenario 7.8.3.5. Argentina market estimates and forecasts, 2018 - 2030 7.9. MEA 7.9.1. South Africa 7.9.1.1. Key country dynamics 7.9.1.2. Competitive scenario 7.9.1.3. Regulatory framework 7.9.1.4. Reimbursement scenario 7.9.1.5. South Africa market estimates and forecasts, 2018 - 2030 7.9.2. Saudi Arabia 7.9.2.1. Key country dynamics 7.9.2.2. Competitive scenario 7.9.2.3. Regulatory framework 7.9.2.4. Reimbursement scenario 7.9.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 7.9.3. UAE 7.9.3.1. Key country dynamics 7.9.3.2. Competitive scenario 7.9.3.3. Regulatory framework 7.9.3.4. Reimbursement scenario 7.9.3.5. UAE market estimates and forecasts, 2018 - 2030 7.9.4. Kuwait 7.9.4.1. Key country dynamics 7.9.4.2. Competitive scenario 7.9.4.3. Regulatory framework 7.9.4.4. Reimbursement scenario 7.9.4.5. Kuwait market estimates and forecasts, 2018 - 2030 Chapter 8. Competitive Landscape 8.1. Recent Developments & Impact Analysis, By Key Market Participants 8.2. Company/Competition Categorization 8.2.1. Innovators 8.3. Vendor Landscape 8.3.1. List of key distributors and channel partners 8.3.2. Key customers 8.3.3. Key company market share analysis 8.3.4. Smith+Nephew 8.3.4.1. Company overview 8.3.4.2. Financial performance 8.3.4.3. Product benchmarking 8.3.4.4. Strategic initiatives 8.3.5. Mölnlycke Health Care AB 8.3.5.1. Company overview 8.3.5.2. Financial performance 8.3.5.3. Product benchmarking 8.3.5.4. Strategic initiatives 8.3.6. Convatec Group PLC 8.3.6.1. Company overview 8.3.6.2. Financial performance 8.3.6.3. Product benchmarking 8.3.6.4. Strategic initiatives 8.3.7. Ethicon (Johnson & Johnson) 8.3.7.1. Company overview 8.3.7.2. Financial performance 8.3.7.3. Product benchmarking 8.3.7.4. Strategic initiatives 8.3.8. URGO 8.3.8.1. Company overview 8.3.8.2. Financial performance 8.3.8.3. Product benchmarking 8.3.8.4. Strategic initiatives 8.3.9. Coloplast Corp. 8.3.9.1. Company overview 8.3.9.2. Financial performance 8.3.9.3. Product benchmarking 8.3.9.4. Strategic initiatives 8.3.10. 3M 8.3.10.1. Company overview 8.3.10.2. Financial performance 8.3.10.3. Product benchmarking 8.3.10.4. Strategic initiatives 8.3.11. Integra LifeSciences 8.3.11.1. Company overview 8.3.11.2. Financial performance 8.3.11.3. Product benchmarking 8.3.11.4. Strategic initiatives 8.3.12. PAUL HARTMANN AG 8.3.12.1. Company overview 8.3.12.2. Financial performance 8.3.12.3. Product benchmarking 8.3.12.4. Strategic initiatives 8.3.13. Dr. Ausbüttel & Co. GmbH 8.3.13.1. Company overview 8.3.13.2. Financial performance 8.3.13.3. Product benchmarking 8.3.13.4. Strategic initiatives 8.3.14. Medline Industries, Inc. 8.3.14.1. Company overview 8.3.14.2. Financial performance 8.3.14.3. Product benchmarking 8.3.14.4. Strategic initiatives 8.3.15. Brightwake Ltd. 8.3.15.1. Company overview 8.3.15.2. Financial performance 8.3.15.3. Product benchmarking 8.3.15.4. Strategic initiatives
SummaryWound Dressing Market Growth & Trends Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Product 1.1.2. Application 1.1.3. End-use 1.1.4. Regional scope 1.1.5. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.3.5.1. Data for primary interviews in North America 1.3.5.2. Data for primary interviews in Europe 1.3.5.3. Data for primary interviews in Asia Pacific 1.3.5.4. Data for primary interviews in Latin America 1.3.5.5. Data for Primary interviews in MEA 1.4. Information or Data Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis (Model 1) 1.6.2. Approach 1: Commodity flow approach 1.6.3. Volume price analysis (Model 2) 1.6.4. Approach 2: Volume price analysis 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Product outlook 2.2.2. Application outlook 2.2.3. End-use outlook 2.2.4. Regional outlook 2.3. Competitive Insights Chapter 3. Wound Dressing Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Market Dynamics 3.2.1. Market driver analysis 3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities 3.2.1.2. Introduction of innovative and advanced wound products 3.2.1.3. Rising geriatric population 3.2.1.4. Increasing number of ambulatory surgical centers (ASCs) 3.2.1.5. Increasing number of accidents 3.2.1.6. Steep rise in the number of hospitals & urgent care centers and increase in hospital admissions 3.2.1.7. Improvements in public and private hospital infrastructure 3.2.2. Market restraint analysis 3.2.2.1. Delayed diagnosis and lower treatment rates in emerging nations 3.2.2.2. High cost of advanced wound care products and chronic wound treatments 3.2.2.3. Stringent manufacturing policies 3.3. Wound dressing market analysis tools 3.3.1. Industry Analysis - Porter’s 3.3.1.1. Supplier power 3.3.1.2. Buyer power 3.3.1.3. Substitution threat 3.3.1.4. Threat of new entrant 3.3.1.5. Competitive rivalry 3.3.2. PESTEL Analysis 3.3.2.1. Political landscape 3.3.2.2. Technological landscape 3.3.2.3. Economic landscape Chapter 4. Wound Dressing Market: Product Estimates & Trend Analysis 4.1. Definitions and Scope 4.1.1. Advanced dressings 4.1.2. Traditional dressings 4.2. Product Market Share, 2023 & 2030 4.3. Segment Dashboard 4.4. Global Wound Dressing Market by Product Outlook 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 4.5.1. Traditional wound dressing 4.5.1.1. Traditional wound dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.2. Gauze 4.5.1.2.1. Gauze market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.3. Tape 4.5.1.3.1. Tape market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.4. Bandages 4.5.1.4.1. Bandages market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.5. Cotton 4.5.1.5.1. Cotton market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.6. Others 4.5.1.6.1. Others market estimates and forecast 2018 to 2030 (USD Million) 4.5.2. Advanced dressings 4.5.2.1. Advanced dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2. Moist dressings 4.5.2.2.1. Moist dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2.2. Foam dressing 4.5.2.2.2.1. Foam dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2.3. Hydrocolloid dressing 4.5.2.2.3.1. Hydrocolloid dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2.4. Film dressing 4.5.2.2.4.1. Film dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2.5. Alginate dressing 4.5.2.2.5.1. Alginate dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2.6. Hydrogel dressing 4.5.2.2.6.1. Hydrogel dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2.7. Collagen dressing 4.5.2.2.7.1. Collagen dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2.8. Other advanced dressing 4.5.2.2.8.1. Other advanced dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.3. Antimicrobial dressings 4.5.2.3.1. Antimicrobial dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.3.2. Silver 4.5.2.3.2.1. Silver market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.3.3. Non-silver 4.5.2.3.3.1. Non-silver market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.4. Active dressings 4.5.2.4.1. Active dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.4.2. Biomaterials 4.5.2.4.2.1. Biomaterials market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.4.3. Skin-substitutes 4.5.2.4.3.1. Skin-substitutes market estimates and forecast 2018 to 2030 (USD Million) Chapter 5. Wound dressing Market: Application Estimates & Trend Analysis 5.1. Definitions and Scope 5.1.1. Chronic wounds 5.1.2. Acute wounds 5.2. Application Market Share, 2023 & 2030 5.3. Segment Dashboard 5.4. Global Wound Dressing Market by Application Outlook 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 5.5.1. Chronic wounds 5.5.1.1. Market estimates and forecast 2018 to 2030 (USD million) 5.5.1.2. Diabetic foot ulcers 5.5.1.2.1. Market estimates and forecast 2018 to 2030 (USD Million) 5.5.1.3. Pressure ulcers 5.5.1.3.1. Market estimates and forecast 2018 to 2030 (USD Million) 5.5.1.4. Venous leg ulcers 5.5.1.4.1. Market estimates and forecast 2018 to 2030 (USD Million) 5.5.1.5. Other chronic wounds 5.5.1.5.1. Market estimates and forecast 2018 to 2030 (USD Million) 5.5.2. Acute wounds 5.5.2.1. Market estimates and forecast 2018 to 2030 (USD million) 5.5.2.2. Surgical & traumatic wounds 5.5.2.2.1. Market estimates and forecast 2018 to 2030 (USD Million) 5.5.2.3. Burns 5.5.2.3.1. Market estimates and forecast 2018 to 2030 (USD Million) Chapter 6. Wound dressing Market: End-use Estimates & Trend Analysis 6.1. Definitions and Scope 6.1.1. Hospitals 6.1.2. Outpatient facilities 6.1.3. Home healthcare 6.1.4. Research & manufacturing 6.2. End-use Market Share, 2023 & 2030 6.3. Segment Dashboard 6.4. Global Wound Dressing Market by End-use Outlook 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 6.5.1. Hospitals 6.5.1.1. Market estimates and forecast 2018 to 2030 (USD million) 6.5.2. Outpatient facilities 6.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million) 6.5.3. Home healthcare 6.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million) 6.5.4. Research & manufacturing 6.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million) Chapter 7. Wound dressing Market: Regional Estimates & Trend Analysis 7.1. Regional Market Share Analysis, 2023 & 2030 7.2. Regional Market Dashboard 7.3. Global Regional Market Snapshot 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030: 7.5. North America 7.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 7.5.2. U.S. 7.5.2.1. Key country dynamics 7.5.2.2. Competitive scenario 7.5.2.3. Regulatory framework 7.5.2.4. Reimbursement scenario 7.5.2.5. U.S. market estimates and forecasts, 2018 - 2030 7.5.3. Canada 7.5.3.1. Key country dynamics 7.5.3.2. Competitive scenario 7.5.3.3. Regulatory framework 7.5.3.4. Reimbursement scenario 7.5.3.5. Canada market estimates and forecasts, 2018 - 2030 7.6. Europe 7.6.1. UK 7.6.1.1. Key country dynamics 7.6.1.2. Competitive scenario 7.6.1.3. Regulatory framework 7.6.1.4. Reimbursement scenario 7.6.1.5. UK market estimates and forecasts, 2018 - 2030 7.6.2. Germany 7.6.2.1. Key country dynamics 7.6.2.2. Competitive scenario 7.6.2.3. Regulatory framework 7.6.2.4. Reimbursement scenario 7.6.2.5. Germany market estimates and forecasts, 2018 - 2030 7.6.3. France 7.6.3.1. Key country dynamics 7.6.3.2. Competitive scenario 7.6.3.3. Regulatory framework 7.6.3.4. Reimbursement scenario 7.6.3.5. France market estimates and forecasts, 2018 - 2030 7.6.4. Italy 7.6.4.1. Key country dynamics 7.6.4.2. Competitive scenario 7.6.4.3. Regulatory framework 7.6.4.4. Reimbursement scenario 7.6.4.5. Italy market estimates and forecasts, 2018 - 2030 7.6.5. Spain 7.6.5.1. Key country dynamics 7.6.5.2. Competitive scenario 7.6.5.3. Regulatory framework 7.6.5.4. Reimbursement scenario 7.6.5.5. Spain market estimates and forecasts, 2018 - 2030 7.6.6. Denmark 7.6.6.1. Key country dynamics 7.6.6.2. Competitive scenario 7.6.6.3. Regulatory framework 7.6.6.4. Reimbursement scenario 7.6.6.5. Denmark market estimates and forecasts, 2018 - 2030 7.6.7. Sweden 7.6.7.1. Key country dynamics 7.6.7.2. Competitive scenario 7.6.7.3. Regulatory framework 7.6.7.4. Reimbursement scenario 7.6.7.5. Sweden market estimates and forecasts, 2018 - 2030 7.6.8. Norway 7.6.8.1. Key country dynamics 7.6.8.2. Competitive scenario 7.6.8.3. Regulatory framework 7.6.8.4. Reimbursement scenario 7.6.8.5. Norway market estimates and forecasts, 2018 - 2030 7.7. Asia Pacific 7.7.1. Japan 7.7.1.1. Key country dynamics 7.7.1.2. Competitive scenario 7.7.1.3. Regulatory framework 7.7.1.4. Reimbursement scenario 7.7.1.5. Japan market estimates and forecasts, 2018 - 2030 7.7.2. India 7.7.2.1. Key country dynamics 7.7.2.2. Competitive scenario 7.7.2.3. Regulatory framework 7.7.2.4. Reimbursement scenario 7.7.2.5. India market estimates and forecasts, 2018 - 2030 7.7.3. China 7.7.3.1. Key country dynamics 7.7.3.2. Competitive scenario 7.7.3.3. Regulatory framework 7.7.3.4. Reimbursement scenario 7.7.3.5. China market estimates and forecasts, 2018 - 2030 7.7.4. South Korea 7.7.4.1. Key country dynamics 7.7.4.2. Competitive scenario 7.7.4.3. Regulatory framework 7.7.4.4. Reimbursement scenario 7.7.4.5. South Korea market estimates and forecasts, 2018 - 2030 7.7.5. Australia 7.7.5.1. Key country dynamics 7.7.5.2. Competitive scenario 7.7.5.3. Regulatory framework 7.7.5.4. Reimbursement scenario 7.7.5.5. Australia market estimates and forecasts, 2018 - 2030 7.7.6. Thailand 7.7.6.1. Key country dynamics 7.7.6.2. Competitive scenario 7.7.6.3. Regulatory framework 7.7.6.4. Reimbursement scenario 7.7.6.5. Thailand market estimates and forecasts, 2018 - 2030 7.8. Latin America 7.8.1. Brazil 7.8.1.1. Key country dynamics 7.8.1.2. Competitive scenario 7.8.1.3. Regulatory framework 7.8.1.4. Reimbursement scenario 7.8.1.5. Brazil market estimates and forecasts, 2018 - 2030 7.8.2. Mexico 7.8.2.1. Key country dynamics 7.8.2.2. Competitive scenario 7.8.2.3. Regulatory framework 7.8.2.4. Reimbursement scenario 7.8.2.5. Mexico market estimates and forecasts, 2018 - 2030 7.8.3. Argentina 7.8.3.1. Key country dynamics 7.8.3.2. Competitive scenario 7.8.3.3. Regulatory framework 7.8.3.4. Reimbursement scenario 7.8.3.5. Argentina market estimates and forecasts, 2018 - 2030 7.9. MEA 7.9.1. South Africa 7.9.1.1. Key country dynamics 7.9.1.2. Competitive scenario 7.9.1.3. Regulatory framework 7.9.1.4. Reimbursement scenario 7.9.1.5. South Africa market estimates and forecasts, 2018 - 2030 7.9.2. Saudi Arabia 7.9.2.1. Key country dynamics 7.9.2.2. Competitive scenario 7.9.2.3. Regulatory framework 7.9.2.4. Reimbursement scenario 7.9.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 7.9.3. UAE 7.9.3.1. Key country dynamics 7.9.3.2. Competitive scenario 7.9.3.3. Regulatory framework 7.9.3.4. Reimbursement scenario 7.9.3.5. UAE market estimates and forecasts, 2018 - 2030 7.9.4. Kuwait 7.9.4.1. Key country dynamics 7.9.4.2. Competitive scenario 7.9.4.3. Regulatory framework 7.9.4.4. Reimbursement scenario 7.9.4.5. Kuwait market estimates and forecasts, 2018 - 2030 Chapter 8. Competitive Landscape 8.1. Recent Developments & Impact Analysis, By Key Market Participants 8.2. Company/Competition Categorization 8.2.1. Innovators 8.3. Vendor Landscape 8.3.1. List of key distributors and channel partners 8.3.2. Key customers 8.3.3. Key company market share analysis 8.3.4. Smith+Nephew 8.3.4.1. Company overview 8.3.4.2. Financial performance 8.3.4.3. Product benchmarking 8.3.4.4. Strategic initiatives 8.3.5. Mölnlycke Health Care AB 8.3.5.1. Company overview 8.3.5.2. Financial performance 8.3.5.3. Product benchmarking 8.3.5.4. Strategic initiatives 8.3.6. Convatec Group PLC 8.3.6.1. Company overview 8.3.6.2. Financial performance 8.3.6.3. Product benchmarking 8.3.6.4. Strategic initiatives 8.3.7. Ethicon (Johnson & Johnson) 8.3.7.1. Company overview 8.3.7.2. Financial performance 8.3.7.3. Product benchmarking 8.3.7.4. Strategic initiatives 8.3.8. URGO 8.3.8.1. Company overview 8.3.8.2. Financial performance 8.3.8.3. Product benchmarking 8.3.8.4. Strategic initiatives 8.3.9. Coloplast Corp. 8.3.9.1. Company overview 8.3.9.2. Financial performance 8.3.9.3. Product benchmarking 8.3.9.4. Strategic initiatives 8.3.10. 3M 8.3.10.1. Company overview 8.3.10.2. Financial performance 8.3.10.3. Product benchmarking 8.3.10.4. Strategic initiatives 8.3.11. Integra LifeSciences 8.3.11.1. Company overview 8.3.11.2. Financial performance 8.3.11.3. Product benchmarking 8.3.11.4. Strategic initiatives 8.3.12. PAUL HARTMANN AG 8.3.12.1. Company overview 8.3.12.2. Financial performance 8.3.12.3. Product benchmarking 8.3.12.4. Strategic initiatives 8.3.13. Dr. Ausbüttel & Co. GmbH 8.3.13.1. Company overview 8.3.13.2. Financial performance 8.3.13.3. Product benchmarking 8.3.13.4. Strategic initiatives 8.3.14. Medline Industries, Inc. 8.3.14.1. Company overview 8.3.14.2. Financial performance 8.3.14.3. Product benchmarking 8.3.14.4. Strategic initiatives 8.3.15. Brightwake Ltd. 8.3.15.1. Company overview 8.3.15.2. Financial performance 8.3.15.3. Product benchmarking 8.3.15.4. Strategic initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
Grand View Research社の医療機器分野での最新刊レポート
本レポートと同じKEY WORD（dressing）の最新刊レポートよくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
